Phase IV clinical trials on banzel are currently in progress. Image courtesy of sardinelly.
-
The main ingredient of banzel is an anti-epileptic agent called rufinamide. -
Banzel is available in the form of 200mg and 400mg tablets. -
Phase IV clinical trials on banzel are currently in progress.
